Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AK104 Combined With Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Cervical Cancer

NCT06062589 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06062589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06062589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AK104 Combined With Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Cervical Cancer
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 11, 2023
Completion date
October 11, 2027
Enrollment
18 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer